Drug interactions
Ezogabine + Octreotide
Severity: Moderate
Ezogabine and Octreotide: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Octreotide can cause bradycardia and QT prolongation, and ezogabine may modestly lengthen the QT interval. The combination may increase proarrhythmic risk, particularly in patients with cardiac disease or electrolyte disturbance.
What this interaction means in plain words
Ezogabine and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Ezogabine belongs to Central Nervous System; Octreotide belongs to Endocrine.
Why it happens
Additive pharmacodynamic effects on cardiac repolarization, with octreotide-related bradycardia also contributing.
What to do
Obtain a baseline ECG and monitor heart rate and QTc during co-therapy. Correct potassium and magnesium abnormalities.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Ezogabine and Octreotide, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Ezogabine
Other interactions of Octreotide
Frequently asked questions
Can I take Ezogabine with Octreotide?
MediHelp rates the interaction as moderate. Ezogabine and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Octreotide can cause bradycardia and QT prolongation, and ezogabine may modestly lengthen the QT interval. The combination may increase proarrhythmic risk, particularly in patients with cardiac disease or electrolyte disturbance.
How serious is the interaction between Ezogabine and Octreotide?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and monitor heart rate and QTc during co-therapy. Correct potassium and magnesium abnormalities.
What other medicines interact with Ezogabine?
MediHelp also lists interactions of Ezogabine with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Ezogabine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
